Insight

Naveen Pemmaraju joined expert panel on myeloproliferative neoplasms at the Think Tank25 Meeting

Naveen Pemmaraju/LinkedIn

May 4, 2025, 17:38

Naveen Pemmaraju joined expert panel on myeloproliferative neoplasms at the Think Tank25 Meeting

Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center, shared a post on LinkedIn:

“Delighted to have had the opportunity this weekend to serve as an invited Faculty Speaker on a high-level panel discussion for Myeloproliferative Neoplasms – MPN – which was moderated by Ruben Mesa, MD at the Think Tank25 meeting overall hosted by Chadi Nabhan, MD, MBA,FACP and team!

A truly unique meeting, focused on a high-yield discussion-based format, across the Hematologic malignancies including top-rate faculty speakers across acute and chronic leukemias, MPN, multiple myeloma and lymphoma and CAR-T subject areas.”

More posts featuring Naveen Pemmaraju on OncoDaily.

cancer Chadi Nabhan Leukemia lymphoma MD Anderson Cancer Center MPN multiple myeloma myeloproliferative neoplasms Naveen Pemmaraju OncoDaily Oncology Ruben Mesa ThinkTank 2025

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Cervical Cancer Screening: Who Needs a Pap Smear or HPV Test and When?

Clinical Trials in Cancer Care: What They Are, How to Join, and What to Expect

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More